| Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo AE Buhl, DJ Waldon, SJ Conrad, MJ Mulholland, KL Shull, MF Kubicek, ... Journal of investigative dermatology 98 (3), 315-319, 1992 | 121 | 1992 |
| Potassium channel conductance as a control mechanism in hair follicles AE Buhl, SJ Conrad, DJ Waldon, MN Brunden Journal of investigative dermatology 101 (1), S148-S152, 1993 | 61 | 1993 |
| Structure–activity relationships of acyloxyamidine cytomegalovirus DNA polymerase inhibitors JA Tucker, TL Clayton, CG Chidester, MW Schulz, LE Harrington, ... Bioorganic & medicinal chemistry 8 (3), 601-615, 2000 | 44 | 2000 |
| Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymerase VA Vaillancourt, MM Cudahy, SA Staley, RJ Brideau, SJ Conrad, ... Bioorganic & medicinal chemistry letters 10 (18), 2079-2081, 2000 | 42 | 2000 |
| Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice SJ Conrad, M El-Aswad, E Kurban, D Jeng, BC Tripp, C Nutting, ... Journal of Experimental & Clinical Cancer Research 34, 1-15, 2015 | 36 | 2015 |
| Deconstruction of Activity-Dependent Covalent Modification of Heme in Human Neutrophil Myeloperoxidase by Multistage Mass Spectrometry (MS4) KF Geoghegan, AH Varghese, X Feng, AJ Bessire, JJ Conboy, ... Biochemistry 51 (10), 2065-2077, 2012 | 31 | 2012 |
| Attenuation of Marek's disease virus by codon pair deoptimization of a core gene SJ Conrad, RF Silva, CJ Hearn, M Climans, JR Dunn Virology 516, 219-226, 2018 | 13 | 2018 |
| Poxviruses as gene therapy vectors: generating poxviral vectors expressing therapeutic transgenes SJ Conrad, J Liu Viral Vectors for Gene Therapy: Methods and Protocols, 189-209, 2019 | 12 | 2019 |
| Oncoselectivity in oncolytic viruses against colorectal cancer SJ Conrad, K Essani Journal of Cancer Therapy 5 (13), 1153, 2014 | 8 | 2014 |
| Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human monocytes/macrophages SJ Conrad, T Raza, EA Peterson, J Liem, R Connor, B Nounamo, ... PLoS Pathogens 18 (9), e1010316, 2022 | 6 | 2022 |
| Identification and Validation of Ikaros (IKZF1) as a Cancer Driver Gene for Marek’s Disease Virus-Induced Lymphomas A Steep, E Hildebrandt, H Xu, C Hearn, D Frishman, M Niikura, JR Dunn, ... Microorganisms 10 (2), 401, 2022 | 5 | 2022 |
| Deletion of the Viral Thymidine Kinase in a Meq-Deleted Recombinant Marek’s Disease Virus Reduces Lymphoid Atrophy but Is Less Protective SJ Conrad, EB Oluwayinka, M Heidari, JK Mays, JR Dunn Microorganisms 10 (1), 7, 2021 | 2 | 2021 |
| Whole Genomic Constellation of Avian Reovirus Strains Isolated from Broilers with Arthritis in North Carolina, USA I Nour, S Alvarez-Narvaez, TL Harrell, SJ Conrad, SK Mohanty Viruses 15 (11), 2191, 2023 | | 2023 |
| Toll-like Receptor Ligands Enhance Vaccine Efficacy against a Virulent Newcastle Disease Virus Challenge in Chickens CW Lee, A Bakre, TL Olivier, S Alvarez-Narvaez, TL Harrell, SJ Conrad Pathogens 12 (10), 1230, 2023 | | 2023 |
| Optimizing the Conditions for Whole-Genome Sequencing of Avian Reoviruses SA Narvaez, TL Harrell, O Oluwayinka, HS Sellers, Z Khalid, R Hauck, ... Viruses 15 (9), 1938, 2023 | | 2023 |
| Targeted Ablation of Exon 2 of the Avian Leukosis Virus-A (ALV-A) Receptor Gene in a Chicken Fibroblast Cell Line by CRISPR Abrogates ALV-A Infection SJ Conrad, JK Mays, CJ Hearn, JR Dunn Avian Diseases 67 (1), 102-107, 2023 | | 2023 |
| Codon Deoptimization of UL54 in meq-Deleted Marek's Disease Vaccine Candidate Eliminates Lymphoid Atrophy but Reduces Vaccinal Protection SJ Conrad, CJ Hearn, RF Silva, JR Dunn Avian Diseases 64 (3), 243-246, 2020 | | 2020 |
| Composition for treating cancerous cells and a method therefor K Essani, D Jeng, SJ Conrad US Patent App. 16/594,630, 2020 | | 2020 |
| Abstract TMIM-077: MYXOMA VIRUS ENHANCES TREATMENT BENEFIT OF CHEMOTHERAPY AND DENDRITIC CELL IMMUNOTHERAPY IN OVARIAN CANCER PRECLINICAL MODEL SJ Conrad, B Nounamo, M Cannon, J Liu Clinical Cancer Research 25 (22_Supplement), TMIM-077-TMIM-077, 2019 | | 2019 |
| MYXOMA VIRUS ENHANCES TREATMENT BENEFIT OF CHEMOTHERAPY AND DENDRITIC CELL IMMUNOTHERAPY IN OVARIAN CANCER PRECLINICAL MODEL SJ Conrad, B Nounamo, M Cannon, J Liu CLINICAL CANCER RESEARCH 25 (22), 164-164, 2019 | | 2019 |
